$5.50
-0.23-4.01%
At close: -
$5.70
0.203.64%
After Hours: 4:19 PM EDT
Comments
Loading...
Emergent BioSolutions Stock Guidance | NYSE:EBS | Benzinga
Emergent BioSolutions issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/03/2025 | EBS | Emergent BioSolutions | FY | 2025 | — | — | — | $750.00M | $850.00M | $1.13B | Get Alert |
| 11/06/2024 | EBS | Emergent BioSolutions | FY | 2024 | — | — | — | $1.06B | $1.13B | $1.12B | Get Alert |
| 08/06/2024 | EBS | Emergent BioSolutions | FY | 2024 | — | — | — | $1.05B | $1.13B | $1.03B | Get Alert |
| 08/06/2024 | EBS | Emergent BioSolutions | Q3 | 2024 | — | — | — | $265.00M | $315.00M | $312.15M | Get Alert |
| 05/01/2024 | EBS | Emergent BioSolutions | FY | 2024 | — | — | — | $1.00B | $1.10B | $1.02B | Get Alert |
| 05/01/2024 | EBS | Emergent BioSolutions | Q2 | 2024 | — | — | — | $160.00M | $210.00M | $244.50M | Get Alert |
| 03/06/2024 | EBS | Emergent BioSolutions | FY | 2024 | — | — | — | $900.00M | $1.10B | $1.18B | Get Alert |
| 03/06/2024 | EBS | Emergent BioSolutions | Q1 | 2024 | — | — | — | $200.00M | $250.00M | $185.40M | Get Alert |
| 01/09/2024 | EBS | Emergent BioSolutions | FY | 2023 | — | — | — | $1.00B | $1.10B | $1.06B | Get Alert |
| 11/08/2023 | EBS | Emergent BioSolutions | FY | 2023 | — | — | — | $1.00B | $1.10B | $1.05B | Get Alert |
| 08/08/2023 | EBS | Emergent BioSolutions | Q3 | 2023 | — | — | — | $210.00M | $250.00M | $326.87M | Get Alert |
| 05/09/2023 | EBS | Emergent BioSolutions | FY | 2023 | — | — | — | $1.10B | $1.20B | $1.13B | Get Alert |
| 02/27/2023 | EBS | Emergent BioSolutions | FY | 2023 | — | — | — | $1.10B | $1.20B | $1.18B | Get Alert |
| 01/09/2023 | EBS | Emergent BioSolutions | FY | 2022 | — | — | — | $1.10B | $1.12B | $1.09B | Get Alert |
| 11/08/2022 | EBS | Emergent BioSolutions | FY | 2022 | — | — | — | $1.05B | $1.10B | $1.20B | Get Alert |
| 08/01/2022 | EBS | Emergent BioSolutions | FY | 2022 | — | — | — | $1.15B | $1.25B | $1.23B | Get Alert |
| 08/01/2022 | EBS | Emergent BioSolutions | Q3 | 2022 | — | — | — | $230.00M | $270.00M | $301.17M | Get Alert |
| 02/24/2022 | EBS | Emergent BioSolutions | Q1 | 2022 | — | — | — | $280.00M | $310.00M | $313.87M | Get Alert |
| 02/24/2022 | EBS | Emergent BioSolutions | FY | 2022 | — | — | — | $1.30B | $1.40B | $1.44B | Get Alert |
| 01/09/2022 | EBS | Emergent BioSolutions | FY | 2022 | — | — | — | $1.40B | $1.50B | $1.44B | Get Alert |
| 01/09/2022 | EBS | Emergent BioSolutions | FY | 2021 | — | — | — | $1.77B | $1.79B | $1.70B | Get Alert |
| 11/04/2021 | EBS | Emergent BioSolutions | FY | 2021 | — | — | — | $1.70B | $1.80B | $1.80B | Get Alert |
| 07/29/2021 | EBS | Emergent BioSolutions | FY | 2021 | — | — | — | $1.70B | $1.90B | $1.80B | Get Alert |
| 07/29/2021 | EBS | Emergent BioSolutions | Q3 | 2021 | — | — | — | $400.00M | $500.00M | $495.36M | Get Alert |
| 04/29/2021 | EBS | Emergent BioSolutions | Q2 | 2021 | — | — | — | $370.00M | $430.00M | $502.27M | Get Alert |
| 04/29/2021 | EBS | Emergent BioSolutions | FY | 2021 | — | — | — | $1.70B | $1.90B | $2.00B | Get Alert |
| 04/04/2021 | EBS | Emergent BioSolutions | FY | 2021 | — | — | — | $1.95B | $2.05B | $2.02B | Get Alert |
| 02/18/2021 | EBS | Emergent BioSolutions | Q1 | 2021 | — | — | — | $330.00M | $370.00M | $411.38M | Get Alert |
| 02/18/2021 | EBS | Emergent BioSolutions | FY | 2021 | — | — | — | $1.95B | $2.05B | $1.93B | Get Alert |
| 01/10/2021 | EBS | Emergent BioSolutions | FY | 2020 | — | — | — | $1.54B | $1.55B | $1.53B | Get Alert |
| 01/10/2021 | EBS | Emergent BioSolutions | FY | 2021 | — | — | — | $1.95B | $2.05B | $1.91B | Get Alert |
| 11/05/2020 | EBS | Emergent BioSolutions | FY | 2020 | — | — | — | $1.52B | $1.58B | $1.53B | Get Alert |
| 07/30/2020 | EBS | Emergent BioSolutions | Q3 | 2020 | — | — | — | $420.00M | $450.00M | $420.17M | Get Alert |
| 07/30/2020 | EBS | Emergent BioSolutions | FY | 2020 | — | — | — | $1.50B | $1.60B | $1.39B | Get Alert |
FAQ
What is the most recent guidance for Emergent BioSolutions (EBS)?
There have been no specific sales or earnings guidance reported for Emergent BioSolutions in recent months.
Browse guidance and forecast on all stocks.